百普赛斯(301080) - 2021 Q3 - 季度财报

Financial Performance - The company's total revenue for the first three quarters of 2021 reached ¥276,138,160.42, representing a 61.51% increase compared to the same period last year[6] - Net profit attributable to shareholders was ¥121,272,419.85, up 55.93% year-on-year[11] - Revenue from non-COVID-19 prevention products was ¥203,780,770.75, a significant increase of 75.46% compared to the previous year[6] - Revenue from COVID-19 prevention products amounted to ¥66,319,384.03, reflecting a 32.87% increase year-on-year[6] - The company's basic earnings per share for the third quarter was ¥0.8194, a 38.91% increase compared to the same period last year[11] - Total operating revenue for the third quarter of 2021 reached ¥276,138,160.42, a 61.5% increase from ¥170,971,809.87 in the same period of 2020[28] - Operating profit for the third quarter was ¥135,421,349.55, up 50.9% from ¥89,753,213.95 year-over-year[28] - Net profit attributable to the parent company was ¥121,272,419.85, compared to ¥77,773,071.57 in the previous year, reflecting a growth of 55.8%[31] - The total comprehensive income for the third quarter was ¥120,874,027.61, up from ¥76,451,381.16 year-over-year, reflecting a growth of 58.1%[31] Assets and Liabilities - Total assets at the end of the reporting period were ¥395,315,523.36, marking a 76.94% increase from the end of the previous year[11] - Total current assets as of September 30, 2021, amount to CNY 293,552,128.27, an increase from CNY 178,958,752.10 as of December 31, 2020[20] - Total liabilities as of September 30, 2021, amounted to ¥74,383,493.65, significantly higher than ¥23,356,216.09 at the end of 2020[24] - Total assets reached CNY 395,315,523.36, up from CNY 223,414,218.19 year-over-year[20] - Total liabilities amounted to 23,356,216.09, a decrease of 17,925,746.39 compared to the previous period[47] - Current liabilities totaled 23,356,216.09, down from 28,659,240.11, indicating a reduction of 5,303,024.02[47] - Non-current liabilities were recorded at 12,622,722.37, consistent with the previous period[47] Shareholder Information - Shareholders' equity increased to ¥321,493,600.95, a rise of 60.50% compared to the previous year-end[11] - Total number of common shareholders at the end of the reporting period is 17, with the top 10 shareholders holding a combined 82.34% of shares[13] - The largest shareholder, Chen Yiding, holds 31.38% of shares, amounting to 18,827,168 shares[13] - The company has no preferred shareholders or restricted shares as of the reporting period[16] Cash Flow - The net cash flow from operating activities for the year-to-date was ¥88,291,930.67, an increase of 33.20% year-on-year[11] - Cash flow from operating activities was ¥267,182,341.95, compared to ¥158,210,982.27 in the same quarter of the previous year, showing a growth of 68.9%[34] - Operating cash inflow totaled CNY 268,202,278.05, an increase of 68.9% compared to CNY 158,842,134.99 in the previous period[37] - Operating cash outflow amounted to CNY 179,910,347.38, up 94.3% from CNY 92,557,311.55 in the prior period[37] - Cash flow from investment activities showed a net outflow of CNY 82,993,830.45, worsening from a net outflow of CNY 29,040,304.42 in the previous period[37] Expenses and Investments - Research and development expenses for the third quarter were ¥40,320,723.17, up from ¥21,579,258.19, indicating a 87.2% increase year-over-year[28] - The company incurred CNY 61,775,731.76 in cash payments to employees, which is a 54.9% increase from CNY 39,898,605.83[37] - The company’s investment cash inflow was CNY 52,038,464.29, a substantial increase from CNY 408,683.71 in the previous period[37] - The company’s cash outflow for purchasing fixed assets and intangible assets was CNY 49,532,294.74, significantly higher than CNY 9,438,988.13 in the prior period[37] Other Information - The weighted average return on net assets was 16.56%, down 7.75% compared to the previous year[11] - The company reported a decrease in other comprehensive income, with a net amount of -¥83,242.91 compared to -¥1,163,018.89 in the previous year[31] - The company has not audited its third-quarter report[50] - The report does not apply to the retrospective adjustment of prior comparative data under the new leasing standards[48] - The company’s capital reserve stands at 55,824,039.12, unchanged from the previous period[47] - The company’s undistributed profits are recorded at 73,386,652.53, remaining stable compared to the previous period[47]

ACROBIOSYSTEMS-百普赛斯(301080) - 2021 Q3 - 季度财报 - Reportify